Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $39.95 ($1.2M) on 2024-02-27, disclosed to the SEC on 2024-02-28.
Scheduled sale ($1.2M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.95 | 10,000 | $400K | 33.6% |
| 2 | $39.54 | 7,471 | $295K | 24.8% |
| 3 | $39.54 | 7,471 | $295K | 24.8% |
| 4 | $39.56 | 2,529 | $100K | 8.4% |
| 5 | $39.56 | 2,529 | $100K | 8.4% |
| Total | $39.68 avg | 30,000 |
| $1.2M |
| 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |